Company news
Kelyniam Global, Inc. (OTC:KLYG) news
Kelyniam Global, Inc. news releases on 6ix. Latest, Aug 11, 2026: Kelyniam Global Announces Q2 2026 Financial Results
Press releases & updates
Kelyniam Global Announces Q2 2026 Financial Results
August 11, 2026
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader
June 1, 2026
Kelyniam Global Announces Strong Q1 2026 Financial Results
May 11, 2026
Kelyniam Global Reports 2025 Financial Results
March 16, 2026
Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants
November 13, 2025
Kelyniam Global Announces Q3 2025 Financial Results
November 10, 2025
Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products
November 5, 2025
Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion™ BCP-PEEK Implant
September 18, 2025
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
September 18, 2025
Kelyniam Global Inc. to Present at the Life Sciences Virtual Investor Forum September 18th
September 16, 2025
Commitment to Investor
September 8, 2025
Kelyniam Global Announces Q2 2025 Financial Results
August 11, 2025
Osteopore Limited (ASX:OSX) Elevates Partnership with Kelyniam for the U.S. Craniofacial Market
May 12, 2025
Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership
May 11, 2025
KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024
March 16, 2025
Kelyniam Corporate Update
January 20, 2025
Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering
December 15, 2024
Kelyniam Global Releases Q3 Financials, Strong Performance Continues
November 10, 2024
Kelyniam Global Releases Strong Q2 Financials
August 11, 2024
Kelyniam Global Releases Q1 Financials
May 12, 2024
NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use
April 1, 2024
Strong Fourth Quarter Powers 2023 Kelyniam Financials
March 16, 2024
Kelyniam Global Releases 3rd Quarter 2023 Financials
December 20, 2023
Kelyniam Global Releases 2nd Quarter 2023 Financials
August 13, 2023
Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products
May 21, 2023
Kelyniam Global Announces Record Sales of $3 million in 2022 Financial Statements
March 15, 2023
Kelyniam Global Announces 3rd Quarter Results
November 15, 2022
Kelyniam Global Announces 1st Half Results Outstanding Quarter and Sales Momentum into the Second Half
August 15, 2022
Kelyniam Announces New Vice President of Sales and Strategic Development
July 11, 2022
Kelyniam Global Announces 1st Quarter Results
May 7, 2022
Kelyniam Global Announces Record Sales and Operating Profit in 2021 Financial Statements
February 14, 2022
Kelyniam Global, Inc., Announces Strategic Licensing Agreement with Fin-ceramica faenza spa to Market Hydroxyapatite Cranial Implant in the U.S.
December 22, 2021
Kelyniam Global Receives U.S. Patent for Integrated Fixation Tabs
November 30, 2021
Kelyniam Global Releases 3rd Quarter 2021 Financials
November 9, 2021
Kelyniam Global, Inc. OTC Trading & Business Matters Update
September 30, 2021
Kelyniam Global Releases 2nd Quarter 2021 Financials Maintains Profitability - Covid Challenges Continue
August 23, 2021